Medical Weight Loss for Parma, Ohio Residents
Parma, Ohio residents get physician-supervised weight loss by telehealth from New Hope Weight Loss: a $119 doctor review, then compounded semaglutide from $166/month or tirzepatide from $233/month.
Physician-supervised GLP-1 programs from $166/month · just $5.50/day, serving Parma through telehealth from our Costa Mesa, California clinic. Doctor review $119. Over 5,400 patients treated.
Why Parma Residents Choose New Hope Weight Loss
Since 2020, New Hope Weight Loss has treated more than 5,400 patients from its Costa Mesa, California clinic, and Parma, Ohio residents get that same physician-led program by telehealth. Pricing is flat and transparent, with care overseen by Dr. Anjmun Sharma, M.D., and no insurance required to start.
Parma patients are cared for entirely through telehealth from our Costa Mesa, California clinic. There is no travel, your consultation with Dr. Sharma, prescription, and follow-ups all happen by secure video.
Although our clinic is physically in Costa Mesa, California, Parma residents receive the same physician-supervised care without leaving Ohio. We care for patients throughout the greater Parma area and the Cleveland metro. Every prescription for Parma is authorized by Dr. Sharma after reviewing your history, and follow-up continues by video throughout the program.
For Parma residents, being seen by video means starting this week instead of waiting for an in-person appointment. Compounded medication arrives in discreet, cold-pack packaging at your Parma address, usually within days.
GLP-1 Weight Loss Programs Available
Semaglutide (90-Day Metabolic Reset), from $166/mo
Our most popular program for Parma patients uses semaglutide, the same active ingredient found in Wegovy® and Ozempic®. In clinical trials of the branded drug, patients lost an average of 15-17% of body weight, with physician oversight and monthly dose adjustments.
Tirzepatide (Advanced Program), from $233/mo · just $7.70/day
For maximum results, tirzepatide uses a dual GLP-1/GIP mechanism that clinical trials showed can reach up to 22.5% body-weight loss.
Doctor review: $119. Medication billed separately. HSA, FSA, Klarna, and Affirm accepted.
How Telehealth Works for Parma
1. Tell us your history through the quiz or intake form. 2. Dr. Sharma confirms your eligibility by secure video, usually within 48 hours. 3. Your compounded medication arrives at your Parma address in cold-pack packaging, with ongoing follow-up from the team, all without leaving home.
Frequently Asked Questions, Parma
Is there a medical weight loss clinic near Parma?
Our physical clinic is in Costa Mesa, California. We serve Parma, Ohio residents through telehealth, the same physician care from Dr. Sharma by secure video, with compounded medication shipped to your address. Telehealth eligibility is confirmed during the consultation.
Do I need to visit in person from Parma?
No. We offer full telehealth consultations. Your physician review, prescription, and ongoing support are all handled remotely, with compounded medication shipped to your Parma address in cold-pack packaging.
How much does treatment cost for Parma patients?
The same as for every patient nationwide: a $119 physician visit, compounded semaglutide from $166/month (a 90-day program is $499), and compounded tirzepatide from $233/month. Medication is billed separately. HSA and FSA are accepted; Klarna and Affirm are available. There is no distance surcharge.
What areas of Parma do you serve?
We serve patients from across Parma by telehealth, including the greater Parma area and the Cleveland metro.
How is medication shipped to Parma patients?
After Dr. Sharma approves your plan, compounded medication ships in discreet, temperature-appropriate packaging directly to your Parma address from the identified 503(a) compounding pharmacy. Most patients receive it within days, with no pharmacy line and no drive.
New Hope Weight Loss | clinic at 1503 South Coast Drive, Suite 322, Costa Mesa, CA 92626 | (657) 837-3342 | Serving Parma, Ohio by telehealth. Telehealth availability and eligibility are confirmed during the medical consultation.
Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. New Hope Weight Loss is not affiliated with or endorsed by these companies. Compounded semaglutide and tirzepatide are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA for safety, effectiveness, or quality.